Resultados da busca - Li‐Kang Zhang
- Mostrando 1 - 2 resultados de 2
-
1
-
2
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology por Sobhana Babu Boga, Yongqi Deng, Liang Zhu, Nan Yang, Alan Cooper, Gerald W. Shipps, Ronald J. Doll, Neng‐Yang Shih, Hugh Zhu, Robert Sun, Tong Wang, Sunil Paliwal, Hon‐Chung Tsui, Xiaolei Gao, Xin Yao, Jagdish Desai, James Wang, Abdul Basit Alhassan, Joseph Kelly, Mehul Patel, Kiran Muppalla, Subrahmanyam Gudipati, Li‐Kang Zhang, Alexei V. Buevich, David Hesk, Donna Carr, Priya Dayananth, Stuart Black, Hong Mei, Kathleen Cox, Bradley Sherborne, Alan Hruza, Li Xiao, Weihong Jin, Brian J. Long, Gongjie Liu, Stacey A. Taylor, Paul T. Kirschmeier, William T. Windsor, Robert Bishop, Ahmed A. Samatar
Publicado em 2018Artigo
Ferramentas de busca:
Assuntos relacionados
Biochemistry
Chemistry
Medicine
Antioxidant
Art
Bioavailability
Biology
Botany
Cancer research
Dual (grammatical number)
Epimedium
Epistemology
Herb
Kinase
Literature
MAPK/ERK pathway
Mechanism (biology)
Medicinal herbs
Oncology
Oral administration
Orally active
Pharmacology
Philosophy
Stem-and-leaf display
Traditional medicine